Researchers have been investigating glucagon-like peptide 1 (GLP-1) receptor co-agonists for their cardiac effects, as detailed in a recent report in Naunyn-Schmiedeberg’s Archives of Pharmacology. GLP-1 and its receptor agonists …
Organ Donation